# Project File Templates Templates for `CLAUDE.md`, `IMPLEMENTATION_PLAN.md`, and the 3 standard tables. v3 updates: Stage 4 (Methods) uses **3-axis structure**, not flat 10-subsection list. Bibliography target removed. --- ## CLAUDE.md Template ```markdown # [Topic] Literature Review Writing Guidelines ## Project info - **Topic**: [specific topic] - **Target journals**: [Tier 1: e.g., Nat Rev Cardiol] / [Tier 2: e.g., JACC Cardiovasc Imaging] / [Tier 3: e.g., Eur Radiol] - **Paradigm spec**: see PARADIGM.md (Phase 0 output) - **Citation integrity**: see references/CITATION_INTEGRITY.md - **Hallucination self-check**: see references/HALLUCINATION_PATTERNS.md ## Terminology Standardization | Unified Term | Avoid Using | |---|---| | coronary CT angiography (CCTA) | cardiac CT, CT angio, CTA (ambiguous) | | centerline (anatomical structure) | midline, vessel line | | [add domain-specific terms] | [variants to avoid] | ## Canonical Paper / Dataset Descriptions To prevent internal inconsistency (HALLUCINATION_PATTERNS.md ▸ Pattern 9), lock in canonical descriptions: | Paper / Dataset | Canonical description | |---|---| | ImageCAS | 1000 cases, single-center, CCTA artery segmentation | | TransCC (Xu et al.) | 3 authors: Chenchu Xu, Meng Li, Xue Wu; Dice 0.730 / IoU 0.582 on ImageCAS | | FISH&CHIPS | NHS national CT-FFR implementation program; publication: Fairbairn TA et al. Nat Med 2025;31(6):1903-1910 | | [add high-value papers] | [verified description] | ## Reference Sources ### ArXiv MCP Search queries used: - "[topic] segmentation transformer" (cs.CV, eess.IV) - "[topic] deep learning" (cs.LG) Date range: last 3 years Downloaded papers: [list arXiv IDs] ### PubMed MCP MeSH queries used: - "Deep Learning"[MeSH] AND "[domain]"[MeSH] - "[method]"[MeSH] AND "diagnosis"[MeSH] Filters: Review, Clinical Trial ### Zotero API: localhost:23119 Relevant collections: - [Collection name 1]: [N papers] - [Collection name 2]: [N papers] ## Literature inventory (3-axis grouping) ### Axis 1: Architectural priors - **CNN-based**: [list verified refs] - **Transformer-based**: [list] - **Mamba / state-space**: [list] ### Axis 2: Inductive priors - **Topology-aware**: [list] - **Multi-task**: [list] - **Graph-based**: [list] ### Axis 3: Data regime - **Self-supervised**: [list] - **Foundation models**: [list] - **Federated**: [list] - **Physics-informed**: [list] ### Clinical / downstream - [list] ## Verdict positions to take (3-5) Plan the 3-5 verdict sentences in advance: - §Methods axis 1 closer: ... - §Methods axis 2 closer: ... - §Methods axis 3 closer: ... - §Clinical translation closer: ... - (optional) §Discussion closer: ... ## Writing-time guardrails (from references/) - Per-claim verification on every `[N]` placed (CITATION_INTEGRITY ▸ Rule 1-5) - Self-scan against 9 hallucination patterns every 5-6 paragraphs (HALLUCINATION_PATTERNS.md) - Vendor names only in Table 3 - Equations only in Box 1 - Max 2 heading levels, no numbered headings ``` --- ## IMPLEMENTATION_PLAN.md Template ```markdown # Implementation Plan: [Review Title] ## Phase 0: Paradigm Capture **Status**: [Not Started / In Progress / Complete] - [ ] Identify 2-3 exemplar reviews from target tier - [ ] Read carefully (60-90 min each) - [ ] Extract style spec to PARADIGM.md - [ ] Re-anchor at start of each Phase 4 writing session ## Phase 1: Project Initialization **Status**: [Not Started / In Progress / Complete] - [ ] CLAUDE.md created with terminology + sources + literature inventory skeleton - [ ] IMPLEMENTATION_PLAN.md (this file) created - [ ] manuscript_draft.md created (empty) - [ ] PARADIGM.md linked ## Phase 2: Literature Collection + Verification **Status**: [Not Started / In Progress / Complete] ### ArXiv (Deep Learning Methods) - [ ] Search "[topic] segmentation" in cs.CV, eess.IV - [ ] Search "[topic] transformer/attention" in cs.CV - [ ] Download key papers (target: 50-80 — discriminate aggressively) - [ ] Read each (abstract + methods + results) - [ ] Note actual module names + actual numbers in working notes ### PubMed (Clinical Literature) - [ ] Search MeSH: "Deep Learning" AND "[domain]" - [ ] Filter by publication type (Review, Clinical Trial) - [ ] Collect clinical validation studies (target: 20-40) - [ ] PubMed WebFetch on each for metadata ### Zotero (User's local library) - [ ] Check existing collections for closed-access papers - [ ] Note Zotero item keys for later fulltext retrieval ### Additional sources - [ ] WebSearch supplementary (IEEE Xplore, Springer) ### Verification (every entry, before adding) - [ ] DOI resolves on Crossref - [ ] First + last author verbatim from first-source - [ ] Journal, year, vol, issue, pages match - [ ] No `xxx` / `[TBD]` placeholders ### Gap analysis - [ ] Negative trials covered? (LLM bias: only positive) - [ ] Inter-vendor reproducibility covered? - [ ] Demographic-bias studies covered? - [ ] Recent 6-month preprints covered? ## Phase 3: Outline + 3-Axis Taxonomy **Status**: [Not Started / In Progress / Complete] - [ ] Top-level sections defined (Introduction / Methods / Applications / Translation / Discussion) - [ ] §Methods structured as **3 H3 subsections** (3 axes): - [ ] §Methods.Architectural priors - [ ] §Methods.Inductive priors - [ ] §Methods.Data regime - [ ] Each paper in literature inventory mapped to an axis - [ ] Table 1 / 2 / 3 designs planned - [ ] Box 1 (metrics) content planned - [ ] Figures (3-5) planned - [ ] Verdict positions for 3 axes selected ## Phase 4: Write with Per-Claim Verification **Status**: [Not Started / In Progress / Complete] For each section, micro-workflow (per CITATION_INTEGRITY.md): - [ ] Re-read the actual cited papers - [ ] Write 2-4 sentences with actual module names + actual numbers - [ ] Verify each `[N]` placed (body↔bib, number, direction) - [ ] Close axis with verdict sentence - [ ] Equations to Box 1, not body - [ ] Vendor names to Table 3, not body - [ ] Self-scan against 9 hallucination patterns every 5-6 paragraphs ### Section progress - [ ] Introduction (Clinical background / Technical challenge / Scope) - [ ] Datasets and evaluation metrics (Box 1, Table 1) - [ ] Methods §Axis 1: Architectural priors - [ ] Methods §Axis 2: Inductive priors - [ ] Methods §Axis 3: Data regime - [ ] Methods Table 2 finalized - [ ] Downstream applications - [ ] Translation to clinical practice (Table 3) - [ ] Outstanding challenges - [ ] Future directions - [ ] Conclusion - [ ] References (cross-checked with body) ## Phase 5: Multi-Agent Peer Review **Status**: [Not Started / In Progress / Complete] - [ ] TeamCreate `manuscript-review` - [ ] Spawn `style-reviewer` teammate (Task 1) - [ ] Spawn `ref-checker` teammate (Task 2) - [ ] Spawn `peer-reviewer` teammate (Task 3) - [ ] Spawn `fact-checker` teammate (Task 4) - [ ] Synthesize 4 reports into 00_team_synthesis.md - [ ] Address all CRITICAL findings - [ ] Address HIGH findings agreed by ≥ 2 reviewers ## Phase 6: Submission Prep **Status**: [Not Started / In Progress / Complete] - [ ] Journal selected (reach + match + safety tiers) - [ ] Presubmission inquiries sent (reach tier, optional) - [ ] Cover letter drafted - [ ] Box vs body duplication scan run - [ ] Section cross-reference scan run - [ ] Figures produced (not placeholders) - [ ] Citation format converted for target journal - [ ] Final self-check checklist passed ## Literature Sources Summary | Source | Query / Collection | Papers | Verified | Status | |---|---|---|---|---| | ArXiv | [query 1] | N | N | [ ] | | ArXiv | [query 2] | N | N | [ ] | | PubMed | [MeSH query] | N | N | [ ] | | Zotero | [collection] | N | N | [ ] | ## Change log ### [Date] - v1.0 - Initial draft completed through Phase 4 ### [Date] - v1.1 - Phase 5 peer review found 8 issues; addressed ### [Date] - v1.2 - Phase 6 submission prep done; sent to [Journal] ``` --- ## Standard Table Templates ### Table 1: Public Datasets ```markdown **Table 1 | Public datasets for [task].** | Dataset | Year | Cases | Annotation type | Access | |---|---|---|---|---| | [Name] | 20XX | N | [type] | [link] | *Cases = unique patients. Where multi-center, the number of sites is given in parentheses. Access notations: O = open, R = restricted (registration), C = commercial.* ``` ### Table 2: Method Comparison ```markdown **Table 2 | Representative deep learning methods for [task].** | Reference | Modality | Family | Architecture | Dataset | Headline metric | Innovation | |---|---|---|---|---|---|---| | [First-author Year] [N] | CCTA | Topology-aware | nnU-Net + clDice | ImageCAS | Dice 0.812 | First clDice on CCTA | *Performance numbers are taken from the original publications and should not be compared directly across rows; datasets, splits and metric definitions differ. Family is the most-engaged inductive prior or training regime, not the only one. CCTA = coronary CT angiography; HD95 = 95th-percentile Hausdorff distance; — = not reported.* ``` ### Table 3: Commercial Products ```markdown **Table 3 | Commercial AI tools for [domain] with regulatory clearance.** | Manufacturer | Product | Indication | Underlying technology | Regulatory | Deployment | Key validation evidence | |---|---|---|---|---|---|---| | HeartFlow | CT-FFR Analysis | CT-FFR | CFD + DL hybrid | FDA cleared (CPT 75580); CE | Cloud-based SaaS | NXT, ADVANCE, PLATFORM, PACIFIC; FISH&CHIPS [N] | | Keya Medical | DeepVessel FFR | CT-FFR | DL surrogate of CFD | FDA, NMPA Class III, CE | Cloud + on-site | Multi-centre Chinese validation [N] | *Listed validation evidence refers to peer-reviewed primary publications, not vendor white papers. NMPA = National Medical Products Administration (China); CFD = computational fluid dynamics.* ``` --- ## Notes ### Why bibliography target removed v2 set "80-120 references" as a quality criterion. This drove Claude to **pad the bibliography**, and padding encouraged fabrication. v3 has no count target. Cite what supports the argument. If your review naturally has 60 high-quality refs, that's enough. If it needs 150, also fine. Quantity is downstream of substance. ### Why 3-axis Methods is the structural commitment v2's coronary review produced 10 flat method H3 subsections. The resulting §Methods read as a textbook chapter, not a flagship review. Flagship reviews compress 10+ method variants into ~3 thematic axes that force comparative synthesis. The 3-axis structure is the most important structural fix in v3.